ACCESSION: MSBNK-SMB_Measured-HSA001P0141003
RECORD_TITLE: Annotated; Metenamine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 116
COMMENT: RAW_SPEC {'2_posi_15623': {'bp': 333267.0, 'sum': 740066.0}, '17_posi_15056': {'bp': 152038.0, 'sum': 354733.0}, '18_posi_15098': {'bp': 152659.0, 'sum': 364407.0}, '5_posi_15076': {'bp': 154996.0, 'sum': 391365.0}, 'ProcedureBlank_15056': {'bp': 155988.0, 'sum': 408556.0}, 'BLK02_15074': {'bp': 170160.0, 'sum': 441194.0}, '15_posi_15161': {'bp': 192728.0, 'sum': 434691.0}, '8_posi_15266': {'bp': 203441.0, 'sum': 481748.0}, '1_posi_15266': {'bp': 213656.0, 'sum': 484476.0}, '18_posi_15517': {'bp': 235130.0, 'sum': 542463.0}, '18_posi_15201': {'bp': 241857.0, 'sum': 494482.0}, '14_posi_15476': {'bp': 283260.0, 'sum': 638370.0}, '9_posi_15559': {'bp': 287007.0, 'sum': 650853.0}, '19_posi_14930': {'bp': 108200.0, 'sum': 269346.0}, '12_posi_14930': {'bp': 109582.0, 'sum': 301880.0}, 'ProcedureBlank_14972': {'bp': 120535.0, 'sum': 339785.0}, '19_posi_15014': {'bp': 121302.0, 'sum': 300406.0}, '2_posi_14908': {'bp': 126155.0, 'sum': 335374.0}, '3_posi_14968': {'bp': 131509.0, 'sum': 347978.0}, '6_posi_14950': {'bp': 134449.0, 'sum': 347841.0}, '10_posi_14950': {'bp': 136982.0, 'sum': 339022.0}, '17_posi_14972': {'bp': 139165.0, 'sum': 328406.0}, '2_posi_15077': {'bp': 151475.0, 'sum': 382707.0}, '11_posi_15159': {'bp': 164719.0, 'sum': 407117.0}, '6_posi_15242': {'bp': 180272.0, 'sum': 439672.0}, '1_posi_15097': {'bp': 182352.0, 'sum': 409425.0}, '4_posi_15137': {'bp': 182772.0, 'sum': 417999.0}, '12_posi_15224': {'bp': 221536.0, 'sum': 477345.0}, 'ProcedureBlank_15391': {'bp': 229975.0, 'sum': 550709.0}, '15_posi_15328': {'bp': 252984.0, 'sum': 572385.0}, '7_posi_15497': {'bp': 280316.0, 'sum': 621242.0}, '14_posi_15031': {'bp': 162492.0, 'sum': 387638.0}, '14_posi_15224': {'bp': 193147.0, 'sum': 460595.0}, '14_posi_15329': {'bp': 241661.0, 'sum': 538400.0}, '5_posi_15518': {'bp': 243809.0, 'sum': 570992.0}, '4_posi_14969': {'bp': 110010.0, 'sum': 297172.0}, '15_posi_14993': {'bp': 142992.0, 'sum': 355374.0}, '2_posi_14991': {'bp': 143110.0, 'sum': 368450.0}, '4_posi_15052': {'bp': 147934.0, 'sum': 363349.0}, '1_posi_15012': {'bp': 150343.0, 'sum': 392795.0}, '13_posi_15054': {'bp': 157999.0, 'sum': 365441.0}, '10_posi_15035': {'bp': 161549.0, 'sum': 356802.0}, '3_posi_15054': {'bp': 186983.0, 'sum': 451982.0}, '9_posi_15139': {'bp': 196004.0, 'sum': 411105.0}, '17_posi_15224': {'bp': 208546.0, 'sum': 495792.0}, '8_posi_15497': {'bp': 237501.0, 'sum': 572134.0}, '8_posi_15391': {'bp': 269249.0, 'sum': 625151.0}, '8_posi_14951': {'bp': 110696.0, 'sum': 297924.0}, '9_posi_15032': {'bp': 121518.0, 'sum': 313596.0}, '1_posi_14929': {'bp': 122007.0, 'sum': 337331.0}, '8_posi_15140': {'bp': 162434.0, 'sum': 379181.0}, '7_posi_15076': {'bp': 167141.0, 'sum': 362562.0}, '17_posi_15139': {'bp': 169162.0, 'sum': 409302.0}, '16_posi_15119': {'bp': 188632.0, 'sum': 442127.0}, '7_posi_15160': {'bp': 211473.0, 'sum': 497646.0}, '5_posi_15265': {'bp': 217255.0, 'sum': 483551.0}, '16_posi_14971': {'bp': 133636.0, 'sum': 308977.0}, '14_posi_14948': {'bp': 135523.0, 'sum': 319557.0}, '12_posi_15014': {'bp': 148370.0, 'sum': 343413.0}, '6_posi_15160': {'bp': 194072.0, 'sum': 422935.0}, '2_posi_15391': {'bp': 254371.0, 'sum': 569732.0}, '12_posi_15117': {'bp': 201231.0, 'sum': 443903.0}, '9_posi_15371': {'bp': 254654.0, 'sum': 577402.0}, '6_posi_15413': {'bp': 297279.0, 'sum': 634602.0}, '13_posi_15350': {'bp': 266476.0, 'sum': 589899.0}, '3_posi_15621': {'bp': 263764.0, 'sum': 639122.0}, '18_posi_15350': {'bp': 231640.0, 'sum': 540433.0}, '10_posi_15223': {'bp': 227495.0, 'sum': 519907.0}, 'BLK02_15157': {'bp': 205629.0, 'sum': 487924.0}, '19_posi_15370': {'bp': 205117.0, 'sum': 485779.0}, '5_posi_15181': {'bp': 200630.0, 'sum': 464038.0}, 'ProcedureBlank_15180': {'bp': 199847.0, 'sum': 451747.0}, '11_posi_15392': {'bp': 199099.0, 'sum': 485693.0}, 'ProcedureBlank_15266': {'bp': 197325.0, 'sum': 465757.0}, '19_posi_15266': {'bp': 189208.0, 'sum': 415909.0}, '19_posi_15181': {'bp': 179417.0, 'sum': 383834.0}, '3_posi_15138': {'bp': 175056.0, 'sum': 415716.0}, '16_posi_15223': {'bp': 169503.0, 'sum': 391585.0}, '13_posi_15182': {'bp': 169329.0, 'sum': 394595.0}, '5_posi_14993': {'bp': 146832.0, 'sum': 360974.0}, '11_posi_14970': {'bp': 104145.0, 'sum': 298750.0}, '12_posi_15370': {'bp': 258553.0, 'sum': 560331.0}, '17_posi_15495': {'bp': 255365.0, 'sum': 598221.0}, '6_posi_15326': {'bp': 245983.0, 'sum': 556839.0}, '15_posi_15434': {'bp': 243756.0, 'sum': 547923.0}, 'BLK02_15371': {'bp': 235485.0, 'sum': 576666.0}, 'BLK02_15266': {'bp': 221906.0, 'sum': 527150.0}, '15_posi_15244': {'bp': 220377.0, 'sum': 506039.0}, 'BLK01_15182': {'bp': 216201.0, 'sum': 623712.0}, '1_posi_15371': {'bp': 199727.0, 'sum': 478391.0}, '3_posi_15224': {'bp': 193751.0, 'sum': 435087.0}, '16_posi_15307': {'bp': 176173.0, 'sum': 417795.0}, '6_posi_15076': {'bp': 171549.0, 'sum': 423507.0}, '11_posi_15077': {'bp': 168978.0, 'sum': 399094.0}, '8_posi_15053': {'bp': 145882.0, 'sum': 355648.0}, '18_posi_15013': {'bp': 136142.0, 'sum': 341028.0}, 'BLK02_15516': {'bp': 292269.0, 'sum': 700696.0}, '4_posi_15622': {'bp': 286992.0, 'sum': 684710.0}, 'BLK02_15601': {'bp': 263632.0, 'sum': 650663.0}, '2_posi_15308': {'bp': 238922.0, 'sum': 558635.0}, '16_posi_15413': {'bp': 233112.0, 'sum': 505899.0}, '2_posi_15182': {'bp': 226489.0, 'sum': 517481.0}, '19_posi_15455': {'bp': 214645.0, 'sum': 513651.0}, '1_posi_15181': {'bp': 179272.0, 'sum': 431754.0}, '14_posi_15642': {'bp': 284587.0, 'sum': 664363.0}, '10_posi_15371': {'bp': 250691.0, 'sum': 547394.0}, '4_posi_15452': {'bp': 246227.0, 'sum': 575990.0}, 'BLK01_15327': {'bp': 198016.0, 'sum': 568932.0}, '4_posi_15224': {'bp': 189290.0, 'sum': 434419.0}, '10_posi_15119': {'bp': 184069.0, 'sum': 420108.0}, '14_posi_15118': {'bp': 177655.0, 'sum': 393916.0}, 'BLK02_14989': {'bp': 168838.0, 'sum': 468627.0}, '19_posi_15098': {'bp': 120776.0, 'sum': 285380.0}, '3_posi_15391': {'bp': 248723.0, 'sum': 566632.0}, 'BLK01_15600': {'bp': 230234.0, 'sum': 614765.0}, '13_posi_15266': {'bp': 211043.0, 'sum': 471861.0}}
COMMENT: RETENTION_TIME_STDEV 0.382
COMMENT: PRECURSOR_M/Z_RAW 141.113068
COMMENT: PRECURSOR_M/Z_STDEV 0.000042
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.443; C6H12N4; [M+H]+; delta(ppm) -0.442522
COMMENT: PROPOSED_MF MS-FINDER 2.929; C6H12N4; [M+H]+; delta(ppm) -0.445346
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.501; C6H12N4; [M+H]+; delta(ppm) -0.445346
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H12N4; [M+H]+; delta(ppm) -0.445346
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.670; C6H12N4; [M+H]+; delta(ppm) -0.445346
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.483; C8H14NO; [M+H]+; delta(ppm) -9.960031
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H12N4; [M+H]+; delta(ppm) -0.445346
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; VKYKSIONXSXAKP-UHFFFAOYSA-N; C6H12N4; Spectral Match to Methenamine from NIST14
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.864; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; Metenamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.569; OKIYPFZZDQLNMP-UHFFFAOYSA-N; [M+H]+; 5-pentyl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; Metenamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.951; OKIYPFZZDQLNMP-UHFFFAOYSA-N; [M+H]+; 5-pentyl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.731; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; 1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; VCTVUJOTOJYMIS-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-propan-2-yl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.105; OIVJDIWINLEWFU-UHFFFAOYSA-N; [M+H]+; 2-(3,5-dimethyl-1,2,4-triazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.103; CUTNSFKUMKABGS-UHFFFAOYSA-N; [M+H]+; N'-(2-methylpyrazol-3-yl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.100; UXVISKUHAHDCFI-UHFFFAOYSA-N; [M+H]+; 2-(1-ethyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; SGBUUHYQJQZIEF-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-2H-triazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; BUEANCSGTDXMMH-UHFFFAOYSA-N; [M+H]+; 3-(2-methyltriazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; HKIVZMPMDHNWNR-UHFFFAOYSA-N; [M+H]+; 3-(4-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; FXVXCWWBFBEURF-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-1H-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; WMLLVXMZSGSSEU-UHFFFAOYSA-N; [M+H]+; 3-(1-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; FXQOTTKAHLPLGZ-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)butan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.092; TYWRRCQYQXNVEK-UHFFFAOYSA-N; [M+H]+; 2-(4,5-dimethyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.082; DWLZOAQNIPAAFO-UHFFFAOYSA-N; [M+H]+; 2-(4-ethyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.080; KYIVZQNAWBHHAT-UHFFFAOYSA-N; [M+H]+; 2-(3-ethyl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; LUXLFSWSHAECCA-UHFFFAOYSA-N; [M+H]+; (1-propyltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.052; MLGQMJALMNGPSR-UHFFFAOYSA-N; [M+H]+; (1-propan-2-yltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; ZFOZOCLSYJLZPG-UHFFFAOYSA-N; [M+H]+; (1-propan-2-yl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; JGGUUJRQUZZUIB-UHFFFAOYSA-N; [M+H]+; 2-(4-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; HIWAIHBATLLXPU-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrazol-4-yl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.037; OWZRZTYYKXCIAI-UHFFFAOYSA-N; [M+H]+; (4-propan-2-yl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.033; FRHFXFXZSQDYBC-UHFFFAOYSA-N; [M+H]+; (3-propan-2-yl-1H-1,2,4-triazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; FBILVWGTLWCYPU-UHFFFAOYSA-N; [M+H]+; 3-(azidomethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; UVRLGILFHWSWKE-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-propan-2-yl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; IGHVGDCSIUTUFP-UHFFFAOYSA-N; [M+H]+; 4-(azidomethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; KEMNTRIYSIFNIW-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpyrazol-3-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.975; BGISKSHLHYGZFQ-UHFFFAOYSA-N; [M+H]+; 1-tert-butyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; PZSRJLZFQGEFSY-RXMQYKEDSA-N; [M+H]+; (2R)-1-(1-methyltriazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.965; QURWPRWUDYEQNR-NTSWFWBYSA-N; [M+H]+; (1S,2R)-2-azidocyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; ODGGHRYHUQOMIE-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)butan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; YYLBLMYFEQNWIL-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)butan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; JYXQLWGUUVLZPQ-UHFFFAOYSA-N; [M+H]+; 1-(5-ethyl-1H-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; KWCLNZQGWCJRBO-RXMQYKEDSA-N; [M+H]+; (1R)-1-(5-methyl-1H-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; UNPBPOSGHGAKDM-UHFFFAOYSA-N; [M+H]+; 5-(2-methylpropyl)-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.896; PXEAJKYSDKTUPF-RXMQYKEDSA-N; [M+H]+; (1R)-1-(3-methyltriazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.895; MHDCDPXQCUJWCH-UHFFFAOYSA-N; [M+H]+; 2-butyl-1-cyanoguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.885; LZTMJFUDZMELMK-UHFFFAOYSA-N; [M+H]+; 2-(5-methyl-1H-1,2,4-triazol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; BLFOJPQSVBUXAO-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-2-(1,2,4-triazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; LNIXWHZGFOEORC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(2H-triazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; OUEULNVXHMKTKS-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-(2-methylpropyl)tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.733; FGCGZUFQSOYAJG-UHFFFAOYSA-N; [M+H]+; 5-(2-methylbutan-2-yl)-2H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -19.303; VKYKSIONXSXAKP; [M+H]+; Ammoform
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.458; MHDCDPXQCUJWCH; [M+H]+; 1-Butyl-3-cyanoguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.162; BLFOJPQSVBUXAO; [M+H]+; 1-(2-Dimethylaminoethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.827; LOLVREZTZUWBEQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.974; OUEULNVXHMKTKS; [M+H]+; 1-Isobutyl-5-methyl-1H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -277.775; NMHCNWRIEUCNEX; [M+H]+; ACMC-20lgjx
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.072; FGCGZUFQSOYAJG; [M+H]+; 5-(1,1-Dimethylpropyl)-5H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.815; VKYKSIONXSXAKP; [M+H]+; Ammoform
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -55.032; VKYKSIONXSXAKP; [M+H]+; 1,3,5,7-tetraazatricyclo[3.3.1.1³,⁷]decane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.053; MHDCDPXQCUJWCH; [M+H]+; Guanidine, 1-butyl-3-cyano-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -218.054; BLFOJPQSVBUXAO; [M+H]+; 1H-1,2,4-Triazole, 1-(2-dimethylaminoethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -241.146; NMHCNWRIEUCNEX; [M+H]+; 2-Amino-5-methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -244.545; UVRLGILFHWSWKE; [M+H]+; 1-Isopropyl-5-methyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.591; LOLVREZTZUWBEQ; [M+H]+; ethyl[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -250.959; BGISKSHLHYGZFQ; [M+H]+; 1-(tert-Butyl)-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -256.007; FRHFXFXZSQDYBC; [M+H]+; [5-(Propan-2-YL)-4H-1,2,4-triazol-3-YL]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -261.071; FGCGZUFQSOYAJG; [M+H]+; 5-(1,1-Dimethylpropyl)-5H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -269.295; OUEULNVXHMKTKS; [M+H]+; 1-Isobutyl-5-methyl-1H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.319; VKYKSIONXSXAKP; [M+H]+; 1,3,5,7-tetraazatricyclo[3.3.1.1³,⁷]decane
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Metenamine, VKYKSIONXSXAKP-UHFFFAOYSA-N; Matching to 3 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0029598;
CH$NAME: Metenamine
CH$NAME: 1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H12N4
CH$EXACT_MASS: 140.106196
CH$SMILES: C1N2CN3CN1CN(C2)C3
CH$IUPAC: InChI=1S/C6H12N4/c1-7-2-9-4-8(1)5-10(3-7)6-9/h1-6H2
CH$LINK: CHEBI CHEBI:6824
CH$LINK: HMDB HMDB0029598
CH$LINK: INCHIKEY VKYKSIONXSXAKP-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:4101
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 30.544
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 141.113410
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-1900000000-7c2bfd21ac6a8366f521
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0445344 23.3769 69.045160 1.6801 6.80 0.4824 94 f{C3H5N2}/-2.75ppm,p-C3H8N2
  70.0649105 24.1132 70.065530 1.8982 7.11 0.4120 100 f{C4H8N1}/-3.07ppm,p-C2H5N3
  71.0601668 41.9722 71.060780 1.5761 8.85 0.7170 115 f{C3H7N2}/-2.92ppm,p-C3H6N2
  85.0760408 120.4022 85.076520 0.9756 15.64 0.8997 116 f{C4H9N2}/0.19ppm,p-C2H4N2
  98.0712827 92.0288 98.071620 1.8150 12.01 0.8873 116 f{C4H8N3}/0.09ppm,p-C2H5N1
  112.0869704 315.7401 112.087175 0.4907 24.99 0.9562 116 f{C5H10N3}/0.42ppm,p-C1H3N1
  113.0706764 26.8669 113.070870 2.1491 8.38 0.3239 96 ?
  124.0866349 59.7578 124.086690 1.9422 22.33 -0.0943 116 f{C6H10N3}/-2.33ppm,p-H3N1
  141.0662514 114.0134 141.066155 1.7935 24.30 0.7075 116 ?
  141.0856614 83.4201 141.085565 2.9557 16.06 0.7594 104 ?
  141.1020264 159.0317 141.101930 0.9780 31.38 0.7969 116 ?
  141.1130364 999.0000 141.112940 1.3323 0.00 1.0000 116 f{C6H13N4}/-3.09ppm,p
  141.1217064 76.5967 141.121610 0.6803 24.37 0.2277 114 ?
  141.1376914 60.9746 141.137595 2.9050 25.95 0.1506 112 ?
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  69.044534 23.38 23
  70.064910 24.11 24
  71.060167 41.97 41
  85.076041 120.40 120
  98.071283 92.03 92
  112.086970 315.74 315
  113.070676 26.87 26
  124.086635 59.76 59
  141.066251 114.01 114
  141.085661 83.42 83
  141.102026 159.03 159
  141.113036 999.00 999
  141.121706 76.60 76
  141.137691 60.97 60
//
